Benzinga | Nov 9, 2020 04:37PM EST

Arena Pharmaceuticals Q3 EPS $(1.69) Beats $(1.87) Estimate, Sales $20.00K Down From $1.35M YoY

Arena Pharmaceuticals (NASDAQ:ARNA) reported quarterly losses of $(1.69) per share which beat the analyst consensus estimate of $(1.87) by 9.63 percent. This is a 15.75 percent decrease over losses of $(1.46) per share from the same period last year. The company reported $20.00 thousand in sales this quarter. This is a 98.52 percent decrease over sales of $1.35 million the same period last year.